Changes in endoscopic activity and classification of lesions with panenteric capsule endoscopy in patients treated for Crohn's disease - a prospective blinded comparison with ileocolonoscopy, faecal calprotectin and C-reactive protein - Articles - Gastroenterology

Further Publications

Mechanistic implications of the Mediterranean diet in patients with newly diagnosed Crohn's disease- multi-omic results from a prospective cohort

Gastroenterology

Godny L, Elial-Fatal S, Arrouasse J, Sharar Fischler T, Reshef L, Kutukov Y, Cohen S, Pfeffer-Gik T, Barkan R, Shakhman S, Friedenberg A, Pauker MH, Rabinowitz KM, Shaham-Barda E, Goren I, Gophna U, Eran-Banai H, Ollech JE, Snir Y, Broitman Y, Avni-Biron I, Yanai H, Dotan I

doi: 10.1053/j.gastro.2024.12.031

Inflammatory Bowel Disease

Mirikizumab Improves Quality of Life and Work Productivity in Patients with Moderately to Severely Active Crohn's Disease: Results from the Phase 3 VIVID-1 study

Am J Gastroenterol

Lee SD, Vermeire S, Ungaro R, Vadhariya A, Durand F, Morris N, Yu G, Fisher DA, Traxler K, Long M

doi: 10.14309/ajg.0000000000003410

Inflammatory Bowel Disease

Deucravacitinib in Patients With Inflammatory Bowel Disease: 12-Week Efficacy and Safety Results From Three Randomized Phase 2 Studies in Crohn's Disease and Ulcerative Colitis

J Crohns Colitis

D'Haens G, Danese S, Panaccione R, Rubin DT, Peyrin-Biroulet L, Matsuoka K, Loftus EV Jr, Kobayashi T, Elsharkawi W, Miceli R, Ahmed S, Luo Y, Napoli A, Vaile J, Dornic Q, Patel A, Schreiber S

doi: 10.1093/ecco-jcc/jjaf080

Inflammatory Bowel Disease

Inflammation-related Proteins Support Diagnosis of Inflammatory Bowel Disease and Are Modified by Exclusive Enteral Nutrition in Children With Crohn's Disease, Especially of Ileal Phenotype

Inflamm Bowel Dis

White B, Svolos V, Gervais L, Jatkowska A, Nichols B, MacDonald J, Seenan JP, Hansen R, Russell RK, Milling S, Gerasimidis K

doi: 10.1093/ibd/izae107

Further Publications

Inter-Rater Disagreements in Applying the Montreal Classification for Crohn's Disease: The Five-Nations Survey Study

United European Gastroenterol J

Ukashi O, Amiot A, Laharie D, Menchén L, Gutiérrez A, Fernandes S, Pessarelli T, Correia F, Gonzalez-Muñoza C, López-Cardona J, Calabrese G, Ferreiro-Iglesias R, Tamir-Degabli N, Dussias NK, Mousa A, Oliveira R, Richard N, Veisman I, Sharif K, Ben-Horin S, Soutullo-Castiñeiras C, Dragoni G, Rotulo S, Favale A, Calméjane L, Bazin T, Elosua A, Lopes S, Felice C, Mauriz V, Rodrigues IC, Jougon J, Botto I, Tavares de Sousa H, Bertani L, Abadía PR, Bernardi A, Zabana Y, Serra-Ruiz X, Viola A, Barreiro-de Acosta M, Yanai H, Armuzzi A, Magro F, Kopylov U

doi: 10.1002/ueg2.12757

Inflammatory Bowel Disease

Perianal fistulising Crohn's disease: utilising the TOpClass classification in clinical practice to provide targeted individualised care

Clin Gastroenterol Hepatol

Hanna LN, Anandabaskaran S, Iqbal N, Geldof J, LeBlanc JF, Dige A, Lundby L, Vermeire S, D'Hoore A, Verstockt B, Bislenghi G, De Looze D, Lobaton T, Van de Putte D, Spinelli A, Carvello M, Danese S, Buskens CJ, Gecse K, Hompes R, Becker M, van der Bilt J, Bemelman W, Sebastian S, Moran G, Lightner AL, Wong SY, Colombel JF, Cohen BL, Holubar S, Ding NS, Behrenbruch C, Sahnan K, Misra R, Lung P, Hart A, Tozer P

doi: 10.1016/j.cgh.2024.06.047

Inflammatory Bowel Disease

Placebo rates in Crohn's disease randomized clinical trials: An individual patient data meta-analysis

Gastroenterology

Solitano V, Hogan M, Singh S, Danese S, Peyrin-Biroulet L, Zou G, Yuan Y, Sands BE, Feagan BG, Dulai PS, Narula N, Ma C, Jairath V

doi: 10.1053/j.gastro.2024.10.009

Inflammatory Bowel Disease

Evaluation of Crohn's Disease Activity: Validation of a Segmental Simple Ultrasound Score in a Multicenter Study

Inflamm Bowel Dis

Ripollés T, Poza J, Martínez-Pérez MJ, Suarez Ferrer C, Blanc E, Paredes JM

doi: 10.1093/ibd/izae213

Inflammatory Bowel Disease

DIAGNOSIS AND MANAGEMENT OF UPPER GASTROINTESTINAL INVOLVEMENT IN ADULT PATIENTS WITH CROHN'S DISEASE: A SYSTEMATIC REVIEW

Clin Gastroenterol Hepatol

Cohen NA, Sror N, Naseer M, Bettenworth D, Lu C, Khedraki R, Abreu M, Atreya R, Al-Bawardy B, Connor SJ, d'Haens G, Dotan I, Dignass A, El Ouali S, Feagan B, Feakins R, Gearry R, Gordon IO, Hedin C, Kobayashi T, Leibovitzh H, Maharshak N, Ollech J, Sebastian S, Siegmund B, Rubin DT, Silverberg MS, Steinwurz F, Torres J, Watermeyer G, Hernandez-Rocha C, Gurizzian P, Silfen A, Tzadok R, Falloon K, Rieder F

doi: 10.1016/j.cgh.2025.03.024

Related content

Mechanistic implications of the Mediterranean diet in patients with newly diagnosed Crohn's disease- multi-omic results from a prospective cohort

Mirikizumab Improves Quality of Life and Work Productivity in Patients with Moderately to Severely Active Crohn's Disease: Results from the Phase 3 VIVID-1 study

Deucravacitinib in Patients With Inflammatory Bowel Disease: 12-Week Efficacy and Safety Results From Three Randomized Phase 2 Studies in Crohn's Disease and Ulcerative Colitis

Inflammation-related Proteins Support Diagnosis of Inflammatory Bowel Disease and Are Modified by Exclusive Enteral Nutrition in Children With Crohn's Disease, Especially of Ileal Phenotype

Inter-Rater Disagreements in Applying the Montreal Classification for Crohn's Disease: The Five-Nations Survey Study

Perianal fistulising Crohn's disease: utilising the TOpClass classification in clinical practice to provide targeted individualised care

Placebo rates in Crohn's disease randomized clinical trials: An individual patient data meta-analysis

Evaluation of Crohn's Disease Activity: Validation of a Segmental Simple Ultrasound Score in a Multicenter Study

DIAGNOSIS AND MANAGEMENT OF UPPER GASTROINTESTINAL INVOLVEMENT IN ADULT PATIENTS WITH CROHN'S DISEASE: A SYSTEMATIC REVIEW